Close
ACHEMA MIDDLE EAST 2026

Advanced Clinical Trial Support Hub Launched in South Korea

Leading healthcare solutions company in Asia, Zuellig Pharma, on November 30, 2025, confirmed through an announcement the grand opening of its new state-of-the-art Clinical...

MGI Tech and JCBio Advance Multi-Omics with DCS Lab Project

MGI Tech Co., Ltd., a developer of advanced life sciences technologies, and JCBio Co., Ltd., a biotechnology company in South Korea, have entered into...

Lupin, Sandoz Collab to Commercialise Biosimilar Ranibizumab

Lupin partners with Sandoz Group AG to commercialise and market its biosimilar ranibizumab worldwide. The product will be commercialised in a number of markets,...

Taiwan Grants Full Approval for NEFECON IgAN Treatment

Everest Medicines, a biopharmaceutical company dedicated to advancing innovative therapies, has announced that Taiwan’s Food and Drug Administration (TFDA) has granted full approval for...

Recombinant DNA Technology Market: A Growth Revolution

Recombinant DNA (rDNA) technology is a key element in modern biotechnology, with applications spanning healthcare, agriculture, and industrial domains. Considered the basis of genetic engineering,...

Asia-Pacific Biologics Contract Development Market Growth

The biologics contract development market in Asia-Pacific is evolving into one of the hottest segments in the world of pharmaceuticals. Bringing together the themes of...

AI Revolutionizing Drug Discovery and Clinical Development

Artificial intelligence (AI) is no longer a solution to be theorized for drug discovery and clinical development, but rather a transformative tool that is changing...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...